HPQ
HP Inc.
HPQ has slightly lower modeled downside risk, despite its lower overall score.
PLTR
Palantir Technologies Inc.
PLTR has the edge over HPQ overall, supported by stronger valuation and stronger fundamentals.
HPQ Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Healthy |
HPQ's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
HPQ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.3x | $19.05 | -34% |
| Forward | 9.3x | $28.88 | — |
| Fair | 9.8x | $25.65 | -11% |
| Current | 11x | $28.88 | — |
| Expensive | 12x | $31.53 | +9.2% |
Historical ranges are pointers, not guarantees.
HPQ's PE is in its expensive range at 11x. If earnings grow as analysts expect, today's price would be 9.3x next year's earnings, in its fair range.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over HPQ in the historical PE scenario, which offers more potential upside but is not a forecast.
HPQ Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect HPQ's earnings to grow, with its revenue and profitability holding steady.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
PLTR has the edge over HPQ on the outlook, with more favorable revenue and profitability expectations.
HPQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.11 | +19% |
| Q3 2026 | $2.62 | -4.4% |
| Q2 2026 | $2.71 | +4.6% |
| Q1 2026 | $2.64 | -5% |
| Q4 2025 | $2.65 | -5.7% |
| Q3 2025 | $2.74 | -3.9% |
| Q2 2025 | $2.59 | -13% |
| Q1 2025 | $2.78 | -19% |
| Q4 2024 | $2.81 | -15% |
HPQ's earnings per share have fallen from their peak: $2.62 over the past year, against $5.61 in mid-2022.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over HPQ on earnings, with more consistent year-over-year improvement.
HPQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $15.7B | +13% |
| Q2 2026 | $14.4B | +9% |
| Q1 2026 | $14.4B | +6.9% |
| Q4 2025 | $14.6B | +4.2% |
| Q3 2025 | $13.9B | +3.1% |
| Q2 2025 | $13.2B | +3.3% |
| Q1 2025 | $13.5B | +2.4% |
| Q4 2024 | $14.1B | +1.7% |
HPQ's revenue has grown year over year for nine quarters in a row: $15.7B last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.7% | +0.6 points |
| Q2 2026 | 4.3% | -0.7 points |
| Q1 2026 | 5.3% | -1 points |
| Q4 2025 | 6.5% | -0.5 points |
| Q3 2025 | 5.1% | -1.8 points |
| Q2 2025 | 5% | -2.5 points |
| Q1 2025 | 6.3% | -0.8 points |
| Q4 2024 | 7% | -0.3 points |
HPQ's operating margin was 5.7% last quarter, up 0.6 points from the same quarter a year ago.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR has the edge over HPQ on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over HPQ on profitability, with a higher operating margin.
HPQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +7.1% |
| Q2 2026 | $756M | +$901M |
| Q1 2026 | $150M | +108% |
| Q4 2025 | $1.4B | -2.9% |
| Q3 2025 | $1.4B | +15% |
| Q2 2025 | -$145M | -131% |
| Q1 2025 | $72M | +$109M |
| Q4 2024 | $1.5B | -19% |
HPQ still generates free cash flow, though less than at its 2021 peak: $3.9B over the past year.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR has the edge over HPQ on cash flow, with more consistent year-over-year improvement.
HPQ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +2M shares |
| 1 year | -2.8% | -27M shares |
| 3 years | -7.5% | -75M shares |
| 5 years | -23% | -272M shares |
| Available history | -39% | -597M shares |
HPQ has the edge over PLTR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300M |
| Q2 2026 | $100M |
| Q1 2026 | $325M |
| Q4 2025 | $500M |
| Q3 2025 | $200M |
| Q2 2025 | $100M |
| Q1 2025 | $100M |
| Q4 2024 | $900M |
HPQ spent $1.2B buying back its own shares over the past year, down 5.8% from the year before.
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
HPQ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.4x | Healthy |
HPQ's net debt is about 1.2 years of its operating earnings (EBITDA), down from 1.6 years a year ago.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has the edge over HPQ on leverage, with a lower net debt burden relative to earnings.
HPQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.2 | Neutral |
| Stochastic | 23.8 | Neutral |
HPQ's weekly RSI is 51 (neutral) and its Stochastic is 24 (neutral).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
HPQ PE vs Technology Sector
| Metric | HPQ | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 60% below |
| PE % | 69 | 35 | 34 pts above |
HPQ has the edge over PLTR on valuation relative to its sector.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
HPQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.4 | 5.1% below |
| 20 week MA | $29.5 | 2.2% below |
| 50 week MA | $24.7 | 17% above |
| 100 week MA | $26.2 | 10% above |
| 200 week MA | $28.8 | 0.5% above |
HPQ has slipped below its 8- and 20-week averages, though it's still 0.5% above its 200-week average.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR has the edge over HPQ on trend strength, trading above more of its moving averages.
HPQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.5 | $24.3 | +18% |
| 2021 | $24.3 | $37.7 | +55% |
| 2022 | $37.7 | $26.8 | -29% |
| 2023 | $26.8 | $30.1 | +12% |
| 2024 | $30.1 | $33.3 | +11% |
| 2025 | $33.3 | $23.3 | -30% |
| 2026 YTD | $23.3 | $28.9 | +24% |
HPQ has the edge over PLTR on returns for 2026, with the stronger performance.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR's yearly returns have swung widely, from +361% in 2024 to −67% in 2022. It's down 9.1% so far in 2026.